| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Merve O\\xc4\\x9fuz, Dolunay G\\xc3\\xbcrses, Furkan Ufuk, M\\xc3\\xbcnevver Y\\xc4\\xb1lmaz, Olcay G\\xc3\\xbcng\\xc3\\xb6. Successful treatment of acute myocardial injury of Duchenne muscular dystrophy with steroids: a case report. Journal of cardiothoracic surgery vol 18 issue 1 2023 36869352 |
duchenne muscular dystrophy (dmd) is an x-linked muscular disease which is caused by the absence of dystrophin. |
2023-03-03 |
2023-03-06 |
Not clear |
| Catherine I Soderstrom, Jennifer Larsen, Carolina Owen, David Gifondorwa, David Beidler, Florence H Yong, Patricia Conrad, Hendrik Neubert, Steven A Moore, Mohamed Hassanei. Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle Biopsies. The AAPS journal vol 25 issue 1 2022 36539515 |
duchenne muscular dystrophy (dmd) is a degenerative muscular disease affecting roughly one in 5000 males at birth. |
2022-12-20 |
2023-01-30 |
human |
| Hye-Geum Kim, Bon-Hoon Koo, Seung Woo Lee, Eun-Jin Cheo. Management of Panic Disorder with Neurofeedback in Patients with Muscular Dystrophy: A Case Report. Alpha psychiatry vol 22 issue 4 2022 36424934 |
duchenne muscular dystrophy (dmd) is the most common hereditary progressive muscular disease. |
2022-11-25 |
2023-01-30 |
Not clear |
| Kristy Iskandar, Agung Triono, Sunartini, Ery Kus Dwianingsih, Braghmandita Widya Indraswari, Ignatia Rosalia Kirana, Gabriele Ivana, Retno Sutomo, Suryono Yudha Patria, Elisabeth Siti Herini, Gunad. Dp71 and intellectual disability in Indonesian patients with Duchenne muscular dystrophy. PloS one vol 17 issue 10 2022 36315559 |
duchenne muscular dystrophy (dmd) is an x-linked recessive progressive muscular disease marked by developmental delays due to mutations in the dmd gene, which encodes dystrophin. |
2022-10-31 |
2023-01-30 |
Not clear |
| Elisa Ferrer-Mallol, Clare Matthews, Madeline Stoodley, Alessandra Gaeta, Elinor George, Emily Reuben, Alex Johnson, Elin Haf Davie. Patient-led development of digital endpoints and the use of computer vision analysis in assessment of motor function in rare diseases. Frontiers in pharmacology vol 13 issue 2022 36172196 |
working in partnership with patient organisation duchenne uk, we co-developed a video-based approach, delivered through a new mobile health platform (dmd home), to assess motor function in patients with duchenne muscular dystrophy (dmd), a genetic, rare, muscular disease characterized by the progressive loss of muscle function and strength. |
2022-09-29 |
2023-01-30 |
human |
| Yuhui Su, Yafeng Son. The new challenge of \"exercise + X\\xe2\\x80\\xb3 therapy for Duchenne muscular dystrophy-Individualized identification of exercise tolerance and precise implementation of exercise intervention. Frontiers in physiology vol 13 issue 2022 35991169 |
duchenne muscular dystrophy (dmd) is an x-linked recessive fatal muscular disease. |
2022-08-22 |
2023-01-30 |
Not clear |
| Panagiota Mitropoulou, Alexander Hobson, Geraint Morton, Brijesh Ananthara. ST-elevation myocardial infarction in a young patient with Duchenne's muscular dystrophy: a case report. European heart journal. Case reports vol 6 issue 5 2022 35582544 |
duchenne's muscular dystrophy (dmd) is an x-linked muscular disease which is caused by the absence of dystrophin. |
2022-05-18 |
2023-01-27 |
Not clear |
| Caorui Lin, Gang Han, Lulu Jia, Yiwen Zhao, Jun Song, Ning Ran, Toshifumi Yokota, Yiqi Seow, HaiFang Yi. Cardio-respiratory and phenotypic rescue of dystrophin/utrophin-deficient mice by combination therapy. EMBO reports vol issue 2022 35393769 |
duchenne muscular dystrophy (dmd) is a systemic progressive muscular disease caused by frame-disrupting mutations in the dmd gene. |
2022-04-08 |
2023-01-27 |
mouse |
| Hirofumi Komaki, Yoshihiro Maegaki, Tsuyoshi Matsumura, Kazuhiro Shiraishi, Hiroyuki Awano, Akinori Nakamura, Satoru Kinoshita, Katsuhisa Ogata, Keiko Ishigaki, Shinji Saitoh, Michinori Funato, Satoshi Kuru, Takahiro Nakayama, Yasuyuki Iwata, Hiroyuki Yajima, Shin'ichi Taked. Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy. Annals of clinical and translational neurology vol 7 issue 2 2021 31957953 |
duchenne muscular dystrophy (dmd) is a progressive muscular disease characterized by chronic cycles of inflammatory and necrotic processes. |
2021-11-10 |
2023-01-26 |
Not clear |
| Yoshitsugu Aoki, Cristina S J Rocha, Taavi Lehto, Shouta Miyatake, Henrik Johansson, Yasumasa Hashimoto, Joel Z Nordin, Imre Mager, Misako Aoki, McClorey Graham, Chaitra Sathyaprakash, Thomas C Roberts, Matthew J A Wood, Mark A Behlke, Samir El Andalouss. Fine Tuning of Phosphorothioate Inclusion in 2'-O-Methyl Oligonucleotides Contributes to Specific Cell Targeting for Splice-Switching Modulation. Frontiers in physiology vol 12 issue 2021 34721051 |
splice-switching antisense oligonucleotide- (sso-) mediated correction of framedisrupting mutation-containing premessenger rna (mrna) transcripts using exon skipping is a highly promising treatment method for muscular diseases such as duchenne muscular dystrophy (dmd). |
2021-11-02 |
2023-01-26 |
Not clear |
| Elisa Domi, Malvina Hoxha, Emanuela Prendi, Bruno Zappacost. A Systematic Review on the Role of SIRT1 in Duchenne Muscular Dystrophy. Cells vol 10 issue 6 2021 34205021 |
duchenne muscular dystrophy (dmd) is a muscular disease characterized by progressive muscle degeneration. |
2021-10-27 |
2023-01-26 |
Not clear |
| Ning Ran, Caorui Lin, Ling Leng, Gang Han, Mengyuan Geng, Yingjie Wu, Scott Bittner, Hong M Moulton, HaiFang Yi. MOTS-c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice. EMBO molecular medicine vol 13 issue 2 2021 33337582 |
antisense oligonucleotide (ao)-mediated exon-skipping therapies show promise in duchenne muscular dystrophy (dmd), a devastating muscular disease caused by frame-disrupting mutations in the dmd gene. |
2021-10-25 |
2023-01-26 |
mouse |
| Neepa Gurbani, John E Pascoe, Sherri Katz, Hemant Sawnan. Sleep disordered breathing: Assessment and therapy in the age of emerging neuromuscular therapies. Pediatric pulmonology vol 56 issue 4 2021 32720756 |
although it may be conventional to relate the use of this term to the most common muscular diseases (duchenne muscular dystrophy [dmd], spinal muscular atrophy [sma], and amyotrophic lateral sclerosis, etc), it is important to extend the term to pathologies manifested by severe neurologic (brain and spinal cord) malformations and injuries. |
2021-10-12 |
2023-01-26 |
Not clear |
| Chia-Wei Lin, Po-Hsiang Tsui, Chun-Hao Lu, Yi-Hsuan Hung, Meng-Ru Tsai, Jeng-Yi Shieh, Wen-Chin Wen. Quantifying Lower Limb Muscle Stiffness as Ambulation Function Declines in Duchenne Muscular Dystrophy with Acoustic Radiation Force Impulse Shear Wave Elastography. Ultrasound in medicine & biology vol 47 issue 10 2021 34284931 |
duchenne muscular dystrophy (dmd) is a progressive muscular disease, but validated imaging tools to quantify muscle microstructure alteration as mobility declines are lacking. |
2021-08-30 |
2023-01-26 |
Not clear |
| Salvo Danilo Lombardo, Maria Sofia Basile, Rosella Ciurleo, Alessia Bramanti, Antonio Arcidiacono, Katia Mangano, Placido Bramanti, Ferdinando Nicoletti, Paolo Fagon. A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy. Genes vol 12 issue 4 2021 33918694 |
duchenne muscular dystrophy (dmd) is a progressive hereditary muscular disease caused by a lack of dystrophin, leading to membrane instability, cell damage, and inflammatory response. |
2021-08-16 |
2023-01-26 |
human |
| Yuko Nitahara-Kasahara, Mutsuki Kuraoka, Yuki Oda, Hiromi Hayashita-Kinoh, Shin'ichi Takeda, Takashi Okad. Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy. Stem cell research & therapy vol 12 issue 1 2021 33541428 |
mscs are attractive candidates for cell-based strategies that target diseases with chronic inflammation, such as duchenne muscular disease (dmd). |
2021-07-05 |
2023-01-26 |
Not clear |
| K R Valetdinova, M A Maretina, Y V Vyatkin, M P Perepelkina, A A Egorova, V S Baranov, A V Kiselev, P M Gershovich, S M Zakia. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C. Stem cell research vol 48 issue 2021 32777771 |
generation of three duchenne muscular dystrophy patient-derived induced pluripotent stem cell (ipsc) lines icgi002-a, icgi002-b and icgi002-c. duchenne muscular dystrophy (dmd) is a severe and rapidly progressive hereditary muscular disease with x-linked recessive inheritance, occurring mainly in males. |
2021-06-21 |
2023-01-26 |
Not clear |
| Elisabetta Catalani, Silvia Bongiorni, Anna Rita Taddei, Marta Mezzetti, Federica Silvestri, Marco Coazzoli, Silvia Zecchini, Matteo Giovarelli, Cristiana Perrotta, Clara De Palma, Emilio Clementi, Marcello Ceci, Giorgio Prantera, Davide Cervi. Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy. Cellular and molecular life sciences : CMLS vol 78 issue 4 2021 32749504 |
dystrophin (dys) mutations predispose duchenne muscular disease (dmd) patients to brain and retinal complications. |
2021-03-03 |
2023-01-26 |
mouse |